Literature DB >> 26468938

Executive Functioning in Children, Adolescents, and Young Adults with Chronic Kidney Disease.

Stephen R Hooper1, Nina Laney, Jerilynn Radcliffe, Divya Moodalbail, Erum A Hartung, Rebecca L Ruebner, Abbas F Jawad, Susan L Furth.   

Abstract

OBJECTIVE: To compare behavior ratings of executive functioning in individuals with chronic kidney disease (CKD), using the Behavior Rating Inventory for Executive Functions (BRIEF), with a typically developing comparison group and to examine the correlation between disease severity and ratings of executive functioning.
METHODS: Participants included 92 individuals with CKD (eGFR < 90 mL/min per 1.73 m), aged 8 to 25 years, recruited from nephrology clinics in both hospital and community settings. The disease severity ranged from CKD Stage II to V. The BRIEF was completed by parents for individuals younger than 18 years of age and the BRIEF-Adult was completed by individuals who were older than 18.
RESULTS: For individuals with CKD younger than 18 years of age, the parent-reported BRIEF revealed significant group differences when compared with controls on the Metacognition Index and the individual scales of Initiate, Working Memory, and Plan/Organize. A large proportion of individuals with CKD were rated as being at-risk for executive dysfunction. For the individuals of 18 years of age and older, there were no significant group differences. The relationship between BRIEF ratings and disease severity was limited to a few scales across both versions of the BRIEF.
CONCLUSION: This study supported the presence of executive dysfunction through a parent report, although the level of impairment was mild and its association with disease severity was related to select executive functions. Few difficulties were reported by older adolescents and young adults with CKD. It will be important for developmental-behavioral pediatricians to be cognizant of the level and pattern of executive function capabilities in their patients with CKD, and possible discrepancies with parent reports, so as to facilitate their management and transition planning.

Entities:  

Mesh:

Year:  2015        PMID: 26468938     DOI: 10.1097/DBP.0000000000000221

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  6 in total

1.  Genomic Disorders and Neurocognitive Impairment in Pediatric CKD.

Authors:  Miguel Verbitsky; Amy J Kogon; Matthew Matheson; Stephen R Hooper; Craig S Wong; Bradley A Warady; Susan L Furth; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

Review 2.  Cognitive remediation in pediatric chronic kidney disease and end-stage kidney disease: rationale, candidate interventions, and applicability.

Authors:  Karina Javalkar; Maria E Ferris; Jessica Cuttance; Stephen R Hooper
Journal:  Pediatr Nephrol       Date:  2017-02-25       Impact factor: 3.714

Review 3.  Neurocognition in Pediatric Chronic Kidney Disease: A Review of Data From the Chronic Kidney Disease in Children (CKiD) Study.

Authors:  Rebecca J Johnson; Lyndsay A Harshman
Journal:  Semin Nephrol       Date:  2021-09       Impact factor: 4.472

4.  Leveraging neuroimaging to understand the impact of chronic kidney disease on the brain.

Authors:  Ellen van der Plas; Lyndsay Harshman
Journal:  Pediatr Nephrol       Date:  2021-11-03       Impact factor: 3.651

5.  Brain Magnetic Resonance Imaging Findings in Children and Young Adults With CKD.

Authors:  Erum A Hartung; Guray Erus; Abbas F Jawad; Nina Laney; Jimit J Doshi; Stephen R Hooper; Jerilynn Radcliffe; Christos Davatzikos; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2018-02-15       Impact factor: 8.860

Review 6.  Impact of Chronic Kidney Disease on Brain Structure and Function.

Authors:  Emily J Steinbach; Lyndsay A Harshman
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.